AVertto
Avertto is dedicated to improving healthcare through innovative stroke monitoring technology. Their mission is to provide early detection and intervention for strokes using AI-powered alerts, enabling timely treatment and better patient outcomes. The company leverages long-term big data and proprietary algorithms to analyze hemodynamic features, detect deviations, and notify responsive care with GPS-enabled healthcare access.
Industries
Nr. of Employees
small (1-50)
Products
Wearable stroke monitoring system
A medical-device system that continuously monitors hemodynamic/pulse-wave features, applies AI to detect deviations from personalized baselines, and delivers mobile alerts with location information to enable early intervention for stroke risk.
Wearable stroke monitoring system
A medical-device system that continuously monitors hemodynamic/pulse-wave features, applies AI to detect deviations from personalized baselines, and delivers mobile alerts with location information to enable early intervention for stroke risk.
Services
Design and conduct of clinical studies (including multi-center and blinded trials) to validate detection performance for stroke/LVO.
Regulatory affairs and quality assurance activities including GMP compliance, quality auditing, and preparation for regulatory submissions.
Development of AI and signal-processing algorithms for waveform quality assessment, occlusion detection, and personalized baseline modeling.
Design and conduct of clinical studies (including multi-center and blinded trials) to validate detection performance for stroke/LVO.
Regulatory affairs and quality assurance activities including GMP compliance, quality auditing, and preparation for regulatory submissions.
Development of AI and signal-processing algorithms for waveform quality assessment, occlusion detection, and personalized baseline modeling.
Expertise Areas
- Stroke monitoring and early detection
- Clinical trial design and validation
- AI-driven time-series analysis
- Signal processing for physiological waveforms
Key Technologies
- Deep learning for time-series physiological data
- Template matching for waveform analysis
- Artifact removal and signal-quality algorithms
- Continuous pulse-wave hemodynamic monitoring
News & Updates
Avertto gains an additional 5M ILS for their stroke monitoring tech, supporting multi-center clinical trials.
Avertto received 5M ILS for further clinical trials and development.
Avertto's real-time stroke detection system won NIS 100,000 in June 2023.
Recognized among 780 startups for potential impact in MENA region in May 2023.
Received 2.5M ILS for stroke monitoring system development.
Received 75K Euro for innovative stroke monitoring prototype in July 2022.
Avertto gains an additional 5M ILS for their stroke monitoring tech, supporting multi-center clinical trials.
Avertto received 5M ILS for further clinical trials and development.
Avertto's real-time stroke detection system won NIS 100,000 in June 2023.
Recognized among 780 startups for potential impact in MENA region in May 2023.
Received 2.5M ILS for stroke monitoring system development.
Received 75K Euro for innovative stroke monitoring prototype in July 2022.